Dr Niranjan Naik
Dr. Niranjan Naik is a renowned senior surgical oncologist, presently the Director of Breast & Gastro-Intestinal Onco-Surgery at Fortis Memorial Research Institute (FMRI), Gurgaon. He trained in surgical oncology from the prestigious Institute Rotary Cancer Hospital (IRCH), All India Institute of Medical Sciences (AIIMS), New Delhi and considered as one of the best breast cancer surgeon Delhi and Gurgaon region.
He has performed more than 12000 onco-surgical operations since 1996. He has successfully done various complex onco-surgical operations including laparoscopic and thoracoscopic procedures. He is also well versed in diagnostic and therapeutic endoscopic procedures. He has been an invited faculty at various international and national conferences. He has published numerous papers and research articles in journals of national and international repute. He has also been a guide and mentor to DNB Surgical Oncology training programme. He has a keen interest in advancements in oncology and was an investigator in a phase III Clinical trial.
Dr. Naik has worked with many renowned organisations over the past 20 years and owing to his vast experience in this field, he is considered as one of the best doctor for breast cancer in Gurgaon and Delhi NCR region.
Work Experience:
- Senior Consultant Surgical Oncologist: Dharamshila Narayana Super Specialty Hospital, Delhi-96.
- Consultant Surgical Oncologist: At Mool Chand KR Hospital, Mata Chanan Devi Hospital, Millennium Hospital, Pusa Road, Karol Bagh, Kailash Hospital, NOIDA
- Associate Consultant: Department of Surgical Oncology, Apollo Cancer Institute, Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi
- Senior Registrar: Department of Surgical Oncology, Apollo Cancer Institute, Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi
- Senior Resident: Department of Surgical Oncology, Institute Rotary Cancer Hospital (IRCH), AIIMS, New Delhi
Research Experience :
- Symptomatic outcome after Laparoscopic Cholecystectomy. (Prospective study of 113 patients undergoing laparoscopic cholecystectomy).
- INVESIGATOR IN PHASE III CLINICAL TRIAL:Comparative PK, Efficacy, Safety and Immunogenicity evaluation of Bmab-200 versus Herceptin®, both in combination with Docetaxel in patients with Her2+ Metastatic Breast Cancer: A Double Blind, Randomised, Active Control, Parallel assignment, Comparative Phase III Clinical Trial.
- Short Title: Bioequivalence of Bmab-200 with Herceptin
- Protocol No: BM200-CT3-001-11 2013
- GUIDE IN DIPLOMATE OF NATIONAL BOARD (DNB) SURGICAL ONCOLOGY THESIS: The role of {18F} FDG PET Scan in evaluation of clinic-pathological response of neo-adjuvant chemotherapy in locally advanced breast cancer, Chief guide, 2014-2017
Qualification:
- MBBS, MS (AIIMS), Onco-Surgery (IRCH, AIIMS), FIAGES
Main Speciality:
- Breast and GI Onco Surgery